[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"Intuitive Surgical\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":196},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,7,0,[8,45,74,97,123,147,173],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":18,"targetDuration":21,"studyType":22,"phases":4,"briefSummary":23,"conditions":24,"keywords":27,"overallStatus":32,"whyStopped":4,"lastUpdateSubmitDate":33,"lastUpdatePostDateStruct":34,"startDateStruct":37,"completionDateStruct":39,"leadSponsor":41,"locationsCount":44},"100587083","european-real-world-registry-for-use-of-the-ion-endoluminal-system-100587083",false,"NCT06923774","European Real-World Registry for Use of the Ion Endoluminal System","A European Multi-Center, Prospective, Single-Arm, Observational Study to Evaluate Real-World Outcomes for the Ion Endoluminal System","Inclusion Criteria:\n\n* Patient is aged 18 years or older at time of consent.\n* Patient is planned to undergo a lung lesion biopsy(s) and\u002For localization procedure(s) utilizing the Ion endoluminal system.\n* Patient is willing and able to give written informed consent for clinical study participation.\n\nExclusion Criteria:\n\n* Patient is participating in an interventional research study or research study with investigational agents with an unknown safety profile that would interfere with participation in this study or study results.\n* Female patient that is pregnant or breast feeding as determined by standard site practices.\n* Patient is legally incapacitated or in a legal\u002Fcourt ordered institution or is part of a known vulnerable population, including but not limited to dependency on the sponsor, hospital or study doctor.\n* Patient is not willing to comply with post-procedure study participation requirements.\n* Investigator, in their professional opinion, has decided that it is in the patient's best interest to not participate in the clinical study.","ALL","18 Years",{"count":19,"type":20},1200,"ESTIMATED","24 Months","OBSERVATIONAL","The objective of this study is to collect collect real-world data for the Ion endoluminal system.",[25,26],"Pulmonary Nodule","Lung Cancer",[28,29,30,31],"Biopsy","Bronchoscopy","pulmonary biopsy","pulmonary nodule localization","RECRUITING","2026-06-29",{"date":35,"type":36},"2026-06-30","ACTUAL",{"date":38,"type":36},"2025-09-09",{"date":40,"type":20},"2029-10",{"name":42,"class":43},"Intuitive Surgical","INDUSTRY",6,{"id":46,"slug":47,"hasResults":11,"nctId":48,"briefTitle":49,"officialTitle":50,"acronym":4,"eligibilityCriteria":51,"healthyVolunteers":11,"sex":16,"minAge":52,"maxAge":4,"enrollmentInfo":53,"targetDuration":4,"studyType":55,"phases":56,"briefSummary":58,"conditions":59,"keywords":61,"overallStatus":65,"whyStopped":4,"lastUpdateSubmitDate":66,"lastUpdatePostDateStruct":67,"startDateStruct":69,"completionDateStruct":71,"leadSponsor":73,"locationsCount":4},"100641260","use-of-force-feedback-instruments-with-the-da-vinci-surgical-system-model-is5000-for-mitral-valve-repair-100641260","NCT07655505","Use of Force Feedback Instruments With the da Vinci Surgical System, Model IS5000 for Mitral Valve Repair","A Prospective, Multicenter Clinical Investigation of the Use of Force Feedback Instruments With the da Vinci Surgical System, Model IS5000 for Mitral Valve Repair (MVr)","Inclusion Criteria:\n\n1. Age ≥22 years.\n2. Subjects with mitral regurgitation (MR) resulting from primary (degenerative) etiology with normal ventricular function (left ventricular function \\> 40%) provided that annuloplasty or ventricular repair is feasible robotically.\n3. Subjects with moderate-severe (Grade 3) or severe (Grade 4) mitral regurgitation (MR) confirmed by transthoracic echocardiography (TTE) or transesophageal echocardiography (TEE) within 60 days of surgery or evaluation for surgery.\n4. Subjects with low-moderate operative risk (Society of Thoracic Surgeons Predicted Risk of Mortality (STS-PROM) score of \\\u003C4%).\n5. Subjects that are able to provide written informed consent using the study informed consent form prior to the study.\n6. Subjects that are willing to comply with protocol-specified follow-up visits.\n7. Subjects must be candidates for minimally invasive surgery (no contraindications to robotic approach). Based on the study Investigator's clinical judgement, the Subject is deemed suitable to undergo multiport robotic-assisted surgery for mitral valve repair.\n\nExclusion Criteria:\n\nPREOPERATIVE EXCLUSION CRITERIA:\n\n1. Subjects with symptomatic mitral regurgitation determined to be at prohibitive risk for mitral valve surgery.\n2. Subjects with previous mitral valve surgery, transcatheter repair, or annuloplasty.\n3. Subjects with prior cardiac surgery (endoscopic, open, or robotic) or ipsilateral thoracic surgery (open, endoscopic, or robotic).\n4. Subjects with planned emergent procedure (e.g., cardiogenic shock, acute decompensation requiring immediate surgery).\n5. Subjects requiring surgery with multiple stages (i.e., mitral repair cannot be completed in a single procedure).\n6. Subject with planned major concomitant surgery for a different medical condition (e.g., coronary artery bypass, cancer resection unrelated to mitral regurgitation).\n7. Subjects with non-reparable anatomy.\n8. Subjects with severe pulmonary hypertension (systolic Pulmonary Artery Pressure \\>70 mmHg).\n9. Subjects with severe renal insufficiency (estimated Glomerular Filtration Rate \\\u003C30 mL\u002Fmin\u002F1.73m²) or liver failure (Child-Pugh C).\n10. Subjects with active infection.\n11. Subjects with contraindication to anesthesia\u002Fsurgery (e.g., severe frailty, uncorrectable coagulopathy).\n12. Subjects with any past or ongoing condition, or personal circumstance, that in the Investigator's judgment places the Subject at high surgical risk, deems them unsuitable for mitral valve repair, or might interfere with study participation or data collection (e.g., severe chronic obstructive pulmonary disease, uncontrolled diabetes, immunocompromised state, non-compliance).\n13. Subjects with severe aortic\u002Ftricuspid valve disease requiring concurrent open surgery.\n14. Subjects who are pregnant, suspected pregnancy, or breastfeeding.\n15. Subjects currently participating in another investigational drug\u002Fdevice study or participation in a significant-risk investigational device study within the past 6 months.\n16. Subject with inability to complete follow-up (e.g., geographic inaccessibility, dementia).\n17. Subjects who belong to a vulnerable population (e.g., prisoners, cognitively impaired individuals unable to consent).\n\nINTRAOPERATIVE EXCLUSION CRITERIA:\n\n1. Subject with hemodynamic or respiratory instability that precludes the Investigator from performing the Robotic Assisted Surgery (RAS).\n2. Subject in whom inadequate visualization makes a minimally invasive approach not feasible, as determined by the Investigator assessment prior to docking the robot.\n3. Subject with adhesions, scarring, and disease status in the body which, in the opinion of the investigator, limits the ability to perform the minimally invasive procedure.\n4. Subject has any other condition that, in the judgment of the Investigator, might interfere with the collection of complete quality data.","22 Years",{"count":54,"type":20},30,"INTERVENTIONAL",[57],"NA","This study aims to test the safety and effectiveness of Force Feedback instruments used during robotic-assisted mitral valve repair with the da Vinci Surgical System, Model IS5000 (dV5).",[60],"Mitral Regurgitation (MR)",[62,63,64],"Mitral Valve Regurgitation","Mitral Valve Disorder","Mitral Regurgitation","NOT_YET_RECRUITING","2026-06-15",{"date":68,"type":36},"2026-06-18",{"date":70,"type":20},"2026-06",{"date":72,"type":20},"2027-06",{"name":42,"class":43},{"id":75,"slug":76,"hasResults":11,"nctId":77,"briefTitle":78,"officialTitle":79,"acronym":80,"eligibilityCriteria":81,"healthyVolunteers":11,"sex":82,"minAge":17,"maxAge":4,"enrollmentInfo":83,"targetDuration":4,"studyType":22,"phases":4,"briefSummary":85,"conditions":86,"keywords":4,"overallStatus":32,"whyStopped":4,"lastUpdateSubmitDate":88,"lastUpdatePostDateStruct":89,"startDateStruct":91,"completionDateStruct":93,"leadSponsor":95,"locationsCount":96},"100505941","generate---next-generation-of-gynecological-surgery---robotic-assisted-surgery-in-gynecological-indications-100505941","NCT05867927","GENERATE - Next GENERATion of GynEcological Surgery - Robotic Assisted Surgery in Gynecological Indications","GENERATE - Next GENERATion of GynEcological Surgery - Robotic Assisted Surgery in Gynecological Indications - A Prospective, Non-interventional, Multi-center, Post Market Clinical Study","GENERATE","Key Inclusion Criteria:\n\n* Woman with 18 years of age or older\n* Patient is willing to participate and to comply with the study procedures as demonstrated by signing the informed consent\n* Patient is a candidate for a gynecological procedure to be performed with the Intuitive Surgical System\n\nKey Exclusion Criteria:\n\n* Life expectancy of less than 1 year\n* Pregnancy, or positive pregnancy test for women prior to menopause or breastfeeding women\n* Current participation in a clinical study, if not pre-approved by Intuitive\n* Individuals who are unable to fully understand all aspects of the study that are relevant to the decision to participate (mentally or verbally), or who could be manipulated or unduly influenced as a result of a compromised position, expectation of benefits or fear of retaliation","FEMALE",{"count":84,"type":20},1250,"GENERATE - Next GENERATion of GynEcological Surgery - Robotic Assisted Surgery in Gynecological Indications\n\nGenerate real-world evidence in the use of the da Vinci Surgical Systems for gynecological indications within the German health care system.",[87],"GYN Disorders","2026-06-01",{"date":90,"type":36},"2026-06-03",{"date":92,"type":36},"2023-10-25",{"date":94,"type":20},"2028-03",{"name":42,"class":43},15,{"id":98,"slug":99,"hasResults":11,"nctId":100,"briefTitle":101,"officialTitle":102,"acronym":4,"eligibilityCriteria":103,"healthyVolunteers":11,"sex":16,"minAge":52,"maxAge":4,"enrollmentInfo":104,"targetDuration":4,"studyType":22,"phases":4,"briefSummary":106,"conditions":107,"keywords":109,"overallStatus":32,"whyStopped":4,"lastUpdateSubmitDate":114,"lastUpdatePostDateStruct":115,"startDateStruct":117,"completionDateStruct":119,"leadSponsor":121,"locationsCount":122},"100564057","retrospective-acute-care-appendectomy-study-100564057","NCT06624215","Retrospective Acute Care Appendectomy Study","A Retrospective Multicenter Evaluation of Short-Term Outcomes After Acute Care Appendectomy","Inclusion Criteria:\n\n* Subject is 22 years of age or older at time of procedure\n* Subject has undergone robotic-assisted or laparoscopic emergent or urgent appendectomy for acute appendicitis between 2018 and 30 days prior to IRB approval\n\nExclusion Criteria:\n\n* Subject with appendiceal neoplasms\n* Subject who underwent a single-port appendectomy\n* Subject who was pregnant or breastfeeding at the time of the procedure",{"count":105,"type":20},1000,"The purpose of this retrospective study is to compare perioperative data for subjects who have undergone an emergent or urgent robotic-assisted or laparoscopic appendectomy for acute appendicitis.",[108],"Acute Appendicitis",[110,111,112,113],"Appendectomy","Robotic-assisted","Acute care","Laparoscopic","2026-04-20",{"date":116,"type":36},"2026-04-22",{"date":118,"type":36},"2024-11-22",{"date":120,"type":20},"2026-11",{"name":42,"class":43},3,{"id":124,"slug":125,"hasResults":11,"nctId":126,"briefTitle":127,"officialTitle":128,"acronym":129,"eligibilityCriteria":130,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":131,"targetDuration":4,"studyType":22,"phases":4,"briefSummary":133,"conditions":134,"keywords":135,"overallStatus":32,"whyStopped":4,"lastUpdateSubmitDate":138,"lastUpdatePostDateStruct":139,"startDateStruct":141,"completionDateStruct":143,"leadSponsor":145,"locationsCount":146},"100519029","lung-cancer-robotic-comparative-study-100519029","NCT06038227","Lung cAncer Robotic Comparative Study","Comparing Outcomes for Minimally Invasive Techniques for Anatomic Lung Resection for Cancer - A Prospective, Comparative, Non-randomized, Open Label Post-market Observational Cohort Study Within Europe","LARCS","Inclusion Criteria:\n\n* Patient diagnosed with clinical stage IA1-2 non-small cell lung cancer at time of procedure\n* Patient scheduled to undergo minimally invasive surgery for NSCLC with either da Vinci robotic assisted surgery or VATs\n* Aged ≥ 18 years\n* Must be willing and able to comply with study requirements\n* Must indicate their understanding of the study and willingness to participate by signing an appropriate informed consent form\n\nExclusion Criteria:\n\n* Patients with clinical stage IA3, II, III, and IV lung cancer\n* Patient receiving a lobectomy\u002Fsegmentectomy as an emergency procedure\n* Patients receiving a lobectomy\u002Fsegmentectomy for metastatic cancer\n* Patients scheduled to receive a bilobectomy or sleeve-lobectomy\n* Mental incapacity to understand or consent to study procedures\n* Anticipated difficulty for patient to comply with protocol requirements\n* Unable to comply with the follow up schedule\n* Pregnant or are planning to become pregnant during the study\n* Life expectancy \\\u003C 12 months",{"count":132,"type":20},512,"To compare outcomes of minimally invasive surgical techniques for the treatment of early-stage non-small cell lung cancer.",[26],[136,137],"Minimally invasive surgery","Robotics","2026-03-31",{"date":140,"type":36},"2026-04-06",{"date":142,"type":36},"2023-07-15",{"date":144,"type":20},"2027-12-30",{"name":42,"class":43},12,{"id":148,"slug":149,"hasResults":11,"nctId":150,"briefTitle":151,"officialTitle":152,"acronym":4,"eligibilityCriteria":153,"healthyVolunteers":11,"sex":16,"minAge":52,"maxAge":4,"enrollmentInfo":154,"targetDuration":4,"studyType":22,"phases":4,"briefSummary":156,"conditions":157,"keywords":4,"overallStatus":32,"whyStopped":4,"lastUpdateSubmitDate":164,"lastUpdatePostDateStruct":165,"startDateStruct":167,"completionDateStruct":169,"leadSponsor":171,"locationsCount":172},"100583714","a-study-to-understand-the-utility-of-the-force-feedback-instruments-in-robotic-procedures-using-da-vinci-5-robot-100583714","NCT06879912","A Study to Understand the Utility of the Force Feedback Instruments in Robotic Procedures Using da Vinci 5 Robot","A Prospective, Post-Market Study to Evaluate the Clinical Utility of the Force Feedback Instruments in RAS Procedures Using the da Vinci 5 Surgical System","Pre-Operative Inclusion Criteria:\n\n1. Age 22 years or older\n2. ASA ≤ 3\n3. The clinical decision has been made to perform multi-port robotic assisted surgery with da Vinci 5 with Force Feedback instruments for the study specified procedure as primary procedure prior to enrollment in the study\n4. Subject or a legally authorized representative is able to provide written informed consent using the study informed consent form prior to the study\n5. Subject is willing and able to comply with the study protocol requirements including follow up schedule\n\nPre-operative Exclusion Criteria:\n\n* Subject receiving an emergent procedure\n* Subject planned to undergo major concomitant surgery for the treatment of a different medical condition than was originally planned\n* Subject with previous ipsilateral surgery (open, endoscopic or robotic) with the same surgical indication\n* Subject with past or ongoing medical conditions (for example: inflammatory bowel disease) which, in the judgment of the Investigator, puts them at high risk for surgery and not appropriate for the study\n* Subject is pregnant or suspected to be pregnant or breastfeeding\n* Subject has any other condition or personal circumstance that, in the judgment of the Investigator, might interfere with the collection of complete quality data\n* Subject is currently participating in or has participated in a study of an investigational agent or a significant risk investigational device study within the past 6 months\n* Subject belongs to a vulnerable population.\n* Subject is contraindicated for anesthesia or surgery.\n* Subject has had previous neoadjuvant therapy, previous chemotherapy, immunotherapy, and\u002For radiation therapy for the treatment of the cancer to be resected within the past 6 months\n\nIntra-operative Exclusion Criteria\n\n* Subject with hemodynamic or respiratory instability, which precludes the Investigator from performing the RAS.\n* Subject in whom inadequate visualization makes a minimally invasive approach not feasible, as determined from the investigator assessment prior to docking the robot.\n* Subject with adhesions, scarring and disease status in the body which in the opinion of the investigator limits the ability to perform the minimally invasive procedure.",{"count":155,"type":20},200,"The goal of this observational study is to understand the utility of force feedback instruments in surgeries that are done using the da Vinci 5 robot.",[158,159,160,161,162,163],"Hernia, Inguinal","Hernia, Ventral","Colorectal","Thoracic","Gynecologic","Partial Nephrectomy","2026-02-23",{"date":166,"type":36},"2026-02-25",{"date":168,"type":36},"2025-05-22",{"date":170,"type":20},"2026-08",{"name":42,"class":43},5,{"id":174,"slug":175,"hasResults":11,"nctId":176,"briefTitle":177,"officialTitle":178,"acronym":4,"eligibilityCriteria":179,"healthyVolunteers":11,"sex":16,"minAge":180,"maxAge":181,"enrollmentInfo":182,"targetDuration":4,"studyType":55,"phases":184,"briefSummary":186,"conditions":187,"keywords":4,"overallStatus":65,"whyStopped":4,"lastUpdateSubmitDate":189,"lastUpdatePostDateStruct":190,"startDateStruct":192,"completionDateStruct":193,"leadSponsor":195,"locationsCount":4},"100619549","phase-3-is-001-injection-in-patients-undergoing-robotic-assisted-colorectal-surgery-100619549","NCT07346066","IS-001 Injection in Patients Undergoing Robotic-Assisted Colorectal Surgery","A Phase 3 Multi-Center Efficacy Study of Filricianine Injection in Patients Undergoing Robotic-Assisted Colorectal Surgery Using the da Vinci Surgical System With Firefly® Fluorescence Imaging","Inclusion Criteria:\n\n1. Male and female participants between the ages of 16 and 75, inclusive\n2. Participant is scheduled to undergo robotic-assisted colectomy using the da Vinci X\u002FXi Surgical System with SFF Fluorescence Imaging Exclusion Criteria\n\n1\\. Participant is pregnant or nursing 2. Participant has known current acute or chronic hepatitis B virus (HBV) or hepatitis C virus (HCV) infection 3. Participant has any of the following screening laboratory values: eGFR \\\u003C 30 mL\u002Fmin\u002F1.73 m2\n\n1. Aspartate aminotransferase (AST) ≥ 2.5 × ULN\n2. Alanine aminotransferase (ALT) ≥ 2.5 × ULN\n3. Total Bilirubin \\> 2mg\u002FdL 4. Participant has any concomitant non-colorectal cancer 5. Participant has any circumstances that, in the judgment of the Investigator, might make them not a suitable candidate for the study 6. Participants have already been enrolled in another investigational drug or device study within the past 6 months 7. Participants with known or suspected hypersensitivity to indocyanine green (ICG) or any components of the formulation used 8. Participant is expected to receive or has received other methods for ureter identification during the surgery (e.g., ureteral stent placement, illuminated catheters, retrograde ICG injections) before the administration of IS-001 9. The duration of the surgery is expected to be less than 90 minutes as determined during preoperative planning.","16 Years","75 Years",{"count":183,"type":20},146,[185],"PHASE3","This study evaluates the safety and efficacy of intravenous injection of IS-001 to aid in intraoperative ureter structure delineation",[188],"Ureter Injury","2026-01-14",{"date":191,"type":36},"2026-01-16",{"date":138,"type":20},{"date":194,"type":20},"2027-08-31",{"name":42,"class":43},""]